These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 21216833

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).
    McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A, Kjekshus J, Waagstein F, Apetrei E, Barrios V, Böhm M, Kamenský G, Komajda M, Mareev V, Wikstrand J, CORONA Study Group.
    J Am Coll Cardiol; 2010 Oct 05; 56(15):1196-204. PubMed ID: 20883926
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).
    Inglis SC, McMurray JJ, Böhm M, Schaufelberger M, van Veldhuisen DJ, Lindberg M, Dunselman P, Hjalmarson A, Kjekshus J, Waagstein F, Wedel H, Wikstrand J, CORONA Study Group.
    Eur J Heart Fail; 2010 Jul 05; 12(7):698-705. PubMed ID: 20501489
    [Abstract] [Full Text] [Related]

  • 25. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group.
    Circ Cardiovasc Qual Outcomes; 2009 Nov 05; 2(6):616-23. PubMed ID: 20031900
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
    Kristensen SL, Køber L, Jhund PS, Solomon SD, Kjekshus J, McKelvie RS, Zile MR, Granger CB, Wikstrand J, Komajda M, Carson PE, Pfeffer MA, Swedberg K, Wedel H, Yusuf S, McMurray JJ.
    Circulation; 2015 Jan 06; 131(1):43-53. PubMed ID: 25406306
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [No reason to start treatment with statins in patients with moderate to severe heart failure].
    Stalenhoef AF.
    Ned Tijdschr Geneeskd; 2008 Mar 01; 152(9):486-8. PubMed ID: 18389878
    [Abstract] [Full Text] [Related]

  • 31. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR.
    J Card Fail; 2007 Nov 01; 13(9):769-73. PubMed ID: 17996827
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
    Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ, Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA), GISSI-Heart Failure (GISSI-HF) Committees and Investigators.
    Circulation; 2015 Apr 28; 131(17):1486-94; discussion 1494. PubMed ID: 25810334
    [Abstract] [Full Text] [Related]

  • 34. Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.
    Broch K, Ueland T, Nymo SH, Kjekshus J, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Cleland JG, Aukrust P, Gullestad L.
    Eur J Heart Fail; 2012 Mar 28; 14(3):268-77. PubMed ID: 22302661
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.
    Majani G, Pierobon A, Pinna GD, Giardini A, Maestri R, La Rovere MT.
    Eur J Cardiovasc Prev Rehabil; 2011 Dec 28; 18(6):836-42. PubMed ID: 21450593
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M, ADHERE Scientific Advisory Committee and Investigators.
    J Am Coll Cardiol; 2007 May 15; 49(19):1943-50. PubMed ID: 17498579
    [Abstract] [Full Text] [Related]

  • 40. [The role of statins in the treatment of heart failure].
    Eren M.
    Turk Kardiyol Dern Ars; 2009 Oct 15; 37(7):501-11. PubMed ID: 20098048
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.